
Wellgistics Health (WGRX) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
10.9M
Gross Profit
692.6K
6.38%
Operating Income
-31.3M
-288.57%
Net Income
-32.4M
-298.53%
EPS (Diluted)
$-0.62
Balance Sheet Metrics
Total Assets
58.1M
Total Liabilities
53.6M
Shareholders Equity
4.5M
Debt to Equity
11.96
Cash Flow Metrics
Operating Cash Flow
-1.6M
Free Cash Flow
-1.6M
Revenue & Profitability Trend
Wellgistics Health Income Statement From 2022 to 2024
Metric | 2024 | 2023 | 2022 |
---|---|---|---|
Revenue | 18.1M | 34.4M | 32.8M |
Cost of Goods Sold | 16.4M | 31.6M | 27.0M |
Gross Profit | 1.8M | 2.8M | 5.7M |
Gross Margin % | 9.7% | 8.1% | 17.5% |
Operating Expenses | |||
Research & Development | - | 375 | 1.4K |
Selling, General & Administrative | 6.8M | 10.1M | 7.1M |
Other Operating Expenses | - | - | - |
Total Operating Expenses | 6.8M | 10.1M | 7.1M |
Operating Income | -6.1M | -12.1M | -3.4M |
Operating Margin % | -33.9% | -35.3% | -10.4% |
Non-Operating Items | |||
Interest Income | - | - | - |
Interest Expense | 831.5K | 1.6M | 287.2K |
Other Non-Operating Income | 120.4K | 98.1K | 966.1K |
Pre-tax Income | -6.9M | -13.6M | -2.7M |
Income Tax | 0 | 0 | 0 |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% |
Net Income | -6.9M | -13.6M | -2.7M |
Net Margin % | -37.8% | -39.6% | -8.4% |
Key Metrics | |||
EBITDA | -4.9M | -7.2M | -2.2M |
EPS (Basic) | $-0.15 | $-0.30 | $-0.06 |
EPS (Diluted) | $-0.15 | $-0.30 | $-0.06 |
Basic Shares Outstanding | 47252081 | 44720000 | 46714665 |
Diluted Shares Outstanding | 47252081 | 44720000 | 46714665 |
Income Statement Trend
Wellgistics Health Balance Sheet From 2022 to 2024
Metric | 2024 | 2023 | 2022 |
---|---|---|---|
Assets | |||
Current Assets | |||
Cash & Equivalents | 1.0M | 1.4K | 0 |
Short-term Investments | - | - | - |
Accounts Receivable | 2.7M | - | - |
Inventory | 9.5M | - | - |
Other Current Assets | 1 | - | - |
Total Current Assets | 15.2M | 338.4K | 0 |
Non-Current Assets | |||
Property, Plant & Equipment | 2.1M | - | - |
Goodwill | 54.8M | - | - |
Intangible Assets | 22.4M | - | - |
Long-term Investments | - | - | - |
Other Non-Current Assets | 1.4M | - | - |
Total Non-Current Assets | 42.2M | 0 | 0 |
Total Assets | 57.3M | 338.4K | 0 |
Liabilities | |||
Current Liabilities | |||
Accounts Payable | 6.3M | 1.0M | 5.2K |
Short-term Debt | 12.6M | 350.0K | - |
Current Portion of Long-term Debt | - | - | - |
Other Current Liabilities | - | - | - |
Total Current Liabilities | 38.0M | 3.2M | 5.2K |
Non-Current Liabilities | |||
Long-term Debt | 12.6M | - | - |
Deferred Tax Liabilities | - | - | - |
Other Non-Current Liabilities | - | - | - |
Total Non-Current Liabilities | 12.6M | 0 | 0 |
Total Liabilities | 50.6M | 3.2M | 5.2K |
Equity | |||
Common Stock | 5.1K | 4.5K | 0 |
Retained Earnings | -9.8M | -2.9M | -5.2K |
Treasury Stock | - | - | - |
Other Equity | - | - | - |
Total Shareholders Equity | 6.7M | -2.9M | -5.2K |
Key Metrics | |||
Total Debt | 25.1M | 350.0K | 0 |
Working Capital | -22.9M | -2.9M | -5.2K |
Balance Sheet Composition
Wellgistics Health Cash Flow Statement From 2022 to 2024
Metric | 2024 | 2023 | 2022 |
---|---|---|---|
Operating Activities | |||
Net Income | -6.9M | -2.9M | -5.2K |
Depreciation & Amortization | 1.1M | - | - |
Stock-Based Compensation | 1.1M | - | - |
Working Capital Changes | 1.8M | 764.2K | 5.2K |
Operating Cash Flow | -2.9M | -2.1M | 0 |
Investing Activities | |||
Capital Expenditures | - | - | - |
Acquisitions | 931.4K | - | - |
Investment Purchases | - | - | - |
Investment Sales | - | - | - |
Investing Cash Flow | 846.4K | - | - |
Financing Activities | |||
Share Repurchases | - | - | - |
Dividends Paid | - | - | - |
Debt Issuance | 0 | - | - |
Debt Repayment | -135.8K | - | - |
Financing Cash Flow | 1.6M | 350.5K | 0 |
Free Cash Flow | -1.6M | -349.1K | 0 |
Net Change in Cash | -400.9K | -1.8M | 0 |
Cash Flow Trend
Wellgistics Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-5.47
Price to Book
10.27
Price to Sales
1.96
PEG Ratio
0.00
Profitability Ratios
Profit Margin
-135.22%
Operating Margin
-288.57%
Return on Equity
-2,124.65%
Return on Assets
-77.95%
Financial Health
Current Ratio
0.36
Debt to Equity
571.67
Per Share Data
EPS (TTM)
$-0.77
Book Value per Share
$0.07
Revenue per Share
$0.59
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
wgrx | 56.8M | -5.47 | 10.27 | -2,124.65% | -135.22% | 571.67 |
Walgreens Boots | 10.5B | 27.10 | 1.46 | -69.58% | -4.07% | 409.88 |
High Tide | 248.5M | -61.20 | 1.77 | -6.69% | -1.76% | 44.69 |
PetMed Express | 62.6M | 303.00 | 0.65 | 0.36% | 0.15% | 1.15 |
Scienture Holdings | 19.5M | 2.37 | 0.25 | -54.26% | 4.39% | 5.30 |
Hong Kong Pharma | 11.5M | 6.26 | 2.31 | -0.59% | -0.13% | 47.60 |
Financial data is updated regularly. All figures are in the company's reporting currency.